A carregar...
Phase II Study of AZD2171 in Patients with Malignant Pleural Mesothelioma: SWOG S0509
BACKGROUND: Malignant pleural mesothelioma (MPM) tumors express VEGF and VEGF receptors. MPM patients have high circulating levels of VEGF, suggesting that tumor angiogenesis is a relevant therapeutic target for MPM. We conducted a phase 2 trial of the VEGFR1/2 TKI AZD2171 in patients with MPM after...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3477852/ https://ncbi.nlm.nih.gov/pubmed/21964533 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e318229586e |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|